121 related articles for article (PubMed ID: 8049012)
1. Cytotoxic activity of some gold(III) complexes.
Cossu F; Matovic Z; Radanovic D; Ponticelli G
Farmaco; 1994 Apr; 49(4):301-2. PubMed ID: 8049012
[TBL] [Abstract][Full Text] [Related]
2. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
[TBL] [Abstract][Full Text] [Related]
4. Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes.
Buckley RG; Elsome AM; Fricker SP; Henderson GR; Theobald BR; Parish RV; Howe BP; Kelland LR
J Med Chem; 1996 Dec; 39(26):5208-14. PubMed ID: 8978849
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of [Pt(pyr)(N-Etlm)Cl4].
Massacesi M; Matovic Z; Ponticelli G
Farmaco; 1993 Sep; 48(9):1327-30. PubMed ID: 8259989
[TBL] [Abstract][Full Text] [Related]
6. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
7. Gold(III) complexes as a new family of cytotoxic and antitumor agents.
Marcon G; Messori L; Orioli P
Expert Rev Anticancer Ther; 2002 Jun; 2(3):337-46. PubMed ID: 12113057
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
Habtemariam A; Melchart M; Fernandez R; Parsons S; Oswald ID; Parkin A; Fabbiani FP; Davidson JE; Dawson A; Aird RE; Jodrell DI; Sadler PJ
J Med Chem; 2006 Nov; 49(23):6858-68. PubMed ID: 17154516
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells.
Yan YK; Cho SE; Shaffer KA; Rowell JE; Barnes BJ; Hall IH
Pharmazie; 2000 Apr; 55(4):307-13. PubMed ID: 10798247
[TBL] [Abstract][Full Text] [Related]
12. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
[TBL] [Abstract][Full Text] [Related]
13. Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.
Messori L; Abbate F; Marcon G; Orioli P; Fontani M; Mini E; Mazzei T; Carotti S; O'Connell T; Zanello P
J Med Chem; 2000 Sep; 43(19):3541-8. PubMed ID: 11000008
[TBL] [Abstract][Full Text] [Related]
14. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
[TBL] [Abstract][Full Text] [Related]
15. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
16. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
[TBL] [Abstract][Full Text] [Related]
17. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study.
Castiñeiras A; Dehnen S; Fuchs A; García-Santos I; Sevillano P
Dalton Trans; 2009 Apr; (15):2731-9. PubMed ID: 19333496
[TBL] [Abstract][Full Text] [Related]
19. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
Najajreh Y; Khazanov E; Jawbry S; Ardeli-Tzaraf Y; Perez JM; Kasparkova J; Brabec V; Barenholz Y; Gibson D
J Med Chem; 2006 Jul; 49(15):4665-73. PubMed ID: 16854072
[TBL] [Abstract][Full Text] [Related]
20. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
